{"id":9206,"date":"2019-10-07T13:46:50","date_gmt":"2019-10-07T17:46:50","guid":{"rendered":"http:\/\/plataformalac.org\/?p=9206"},"modified":"2019-10-25T04:07:15","modified_gmt":"2019-10-25T08:07:15","slug":"global-fund-partnership-said-to-have-saved-32-million-lives-up-to-end-2018","status":"publish","type":"post","link":"https:\/\/plataformalac.org\/en\/2019\/10\/global-fund-partnership-said-to-have-saved-32-million-lives-up-to-end-2018\/","title":{"rendered":"Global Fund partnership said to have saved 32 million lives up to end 2018"},"content":{"rendered":"\n

Global Fund partnership said to have saved 32 million lives up to end 2018<\/p>\n\n\n\n

Source: aidspan.org<\/a><\/p>\n\n\n\n

Author:<\/strong>\u00a0David Garmaise<\/p>\n\n\n\n

Fund releases Results Report 2019 in the run-up to the Sixth Replenishment Conference<\/p>\n\n\n\n

The Global Fund estimates that health programs supported by the Fund resulted in 32 million lives saved for the period ending December 2018. This figure was included in Results Report 2019<\/a>, which the Fund released on 19 September 2019.<\/p>\n\n\n\n

The Results Report 2019 provides data for the year 2018. This is the second year of reporting using a revised methodology adopted by the Fund in 2018. Under the revised methodology, most of the results are reported on an annual basis (as opposed to a cumulative basis which the Fund previously used). The lives saved estimates is an exception to the new norm; it is still reported on a cumulative basis.<\/p>\n\n\n\n

In 2018, the Global Fund estimated<\/a> that 27 million lives were saved to end December 2017 in countries where the Fund invests. This indicates that an additional five million lives were saved between December 2017 and December 2018. However, the Global Fund cautions against comparing the 2018 estimates against the 2017 data. In a Note on Methodology included in the Results Report 2019, the Fund explained that:<\/p>\n\n\n\n

\u201c2018 marks the first year in the 2018-2020 grant implementation cycle. The country coordinating mechanism (CCM) \u2026 adapts performance framework agreements for each new grant cycle\u2026. As the associated indicators identified by the CCMs can significantly change from one cycle to the next, some 2018 results are not directly comparable to the results of the previous year. This is particularly notable for HIV prevention services, which are an aggregation of a range of services determined by countries and tracked at national or subnational level.\u201d<\/p>\n\n\n\n

For this reason, we have refrained from making comparisons between end 2018 estimates and end 2017 data in this article.<\/p>\n\n\n\n

(Note: A majority of grants emanating from the 2017-2019 allocations are being implemented over the period 2018-2020. However, this is not the case for all grants.)<\/p>\n\n\n\n

The Results Report 2019 also includes some analysis of the data and describes some of the challenges that lie ahead. It is the last results report to be produced before the Sixth Replenishment Conference on 10 October in Lyon, France.<\/p>\n\n\n\n

Peter Sands, the Global Fund\u2019s Executive Director, said in a call with the Global Fund Advocate Network last week that the Results Report \u201cprovides an occasion to go back to [donors] with new news\u201d. He said that the report demonstrates that the Global Fund continues \u201cto deliver huge outcomes and impact, most notably in the 32 million lives saved,\u201d but that the report also indicates why it is that the world needs to \u2018step up the fight\u2019.<\/p>\n\n\n\n

\u201cThere\u2019s enough sobering news in the Results Report that just continuing as we are is really not good enough.\u201d The \u201cdouble message\u201d about enormous impact and ongoing huge need \u201cis worth ensuring that everybody hears out of the report,\u201d Sands said.<\/p>\n\n\n\n

In addition to the 32 million lives saved estimate, other high-level results for the period ending in December 2018 are as follows:<\/p>\n\n\n\n
People receiving antiretroviral treatment<\/em><\/td>18.9 million<\/strong><\/td><\/tr>
People with TB treated<\/em><\/td>5.3 million<\/strong><\/td><\/tr>
Mosquito nets distributed<\/em><\/td>131 million<\/strong><\/td><\/tr><\/tbody><\/table>\n\n\n\n

In a note<\/a> on its website, the Global Fund said that it reports full national results for the countries where it invests, rather than reporting solely on the specific projects or interventions it funds. \u201cThis reflects a core principle of the Global Fund: that we support national health programs and strategies to achieve national goals. By reporting full national results, we can show the impact of the programs we support together with all partners and demonstrate where countries are on the trajectory toward achieving 2030 targets to end the epidemics,\u201d the Fund said.<\/p>\n\n\n\n

In the balance of this article, we provide additional results for each of the three diseases.<\/p>\n\n\n\n

Results for HIV<\/strong><\/p>\n\n\n\n

The number of new HIV infections in 2018 is estimated to be 1.7 million. The Global Fund said that this number is \u201cunacceptably high\u201d and that it is not dropping fast enough to meet the UNAIDS target of fewer than 500,000 people infected per year by 2020.<\/p>\n\n\n\n

\u201cPersistent gender and human rights barriers drive new infections and reduce uptake and retention of health services,\u201d the Results Report 2019 said. As a result, people from key populations and their partners now account for over half of all new infections. Men who have sex with men, sex workers, prisoners, transgender people and people who inject drugs are up to 22 times more likely to acquire HIV than the general population.<\/p>\n\n\n\n

Figure 1 <\/em><\/strong>(Source: Results Report 2019)<\/em><\/p>\n\n\n\n

\"\"\/<\/figure>\n\n\n\n

In addition, the report said, girls and young women age 15-24 in sub-Saharan Africa are twice as likely to be HIV-positive compared to young men of the same age. In the hardest-hit countries, the number is six times as high.<\/p>\n\n\n\n

HIV drug resistance is an increasing global problem, the report said. In sub-Saharan Africa, over 10% of people starting antiretroviral therapy have a strain of HIV that is resistant to some of the most widely used first-line HIV drugs.<\/p>\n\n\n\n

Other HIV-related results include the following:<\/p>\n\n\n\n